Medicare’s Policy on Alzheimer’s Drugs Comes Under Fire at House Hearing
WASHINGTON — House members on both sides of the aisle were in surprising agreement on a number of healthcare issues Wednesday, most notably the need for Medicare to reconsider its coverage decision on amyloid-inhibiting Alzheimer’s drugs such as aducanumab (Aduhelm) and lecanemab (Leqembi). “There’s been a lot of attention to a decision by CMS [the […]
Who Should Trans Athletes Compete Against?
The debate over transgender athletes is often framed as one between two opposing sides. One side suggests that biology is of paramount importance in sport, that the biological differences between transgender women and cisgender women provide the former group with unfair advantages, and that if women are to succeed in sport, then trans women must […]